BioSpace News Archive

One of the leading causes of death is cardiovascular diseases followed by cancer.

In biomanufacturing, high throughout process development tools and technology platforms could be engaged for a simpler and faster development of downstream chromatography processes.

Growth in the demand for affordable medicines, rise in pressure to augment health care costs, surge in the adoption of bio-similar products, anticipated loss of patents over the period of forecast, and increase in the research & development activities for the development of various complex molecules are suitable for injectable dosage forms, and technological advancements

There has been a groundswell of interest in the application of nanotechnology for developing drug delivery systems, on account of unique properties nanoparticles have in vitro and in vivo.

Also known as genome editing with engineered nucleases, genome editing is a method of altering DNA within a cell in a safe manner.

POINT Biopharma Inc. announced the appointment of Todd Hockemeyer as Executive Vice President of US Manufacturing Operations.

Ampio Pharmaceuticals, Inc. announced that it is preparing an expanded access FDA protocol to study potential benefit of nebulized treatment with Ampion in SARS-Cov-2 induced Acute Respiratory Distress Syndrome, an immediately life-threatening condition.

Viriom Inc announces the company’s activities to address the COVID-19 public health crisis, including supporting the experimental use of the HIV medicine, Elpida (elsulfavirine) and Viriom’s experimental flu medicines AV5080, AV5124 and AV5126 to determine their efficacy in the treatment of COVID-19.

EUCRISA is the first and only 100% steroid-free, topical prescription medication approved for patients as young as 3 months of age in the United States

Microbix Biosystems Inc. announces the appointment of The Medical Supply Company of Ireland as a distributor.